GlassScriptPhysician profile
Seth Lewis Maxwell
NPI 1891292447
$5,468.06
in general payments reported to CMS, 2019-2025
25 companies · $417 in 2025
The $417 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.07 · 2021: $272 · 2022: $1,444 · 2023: $1,519 · 2024: $1,801 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,933 · Travel and Lodging: $535 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,932.75 |
| Travel and Lodging | $535.27 |
| Education | $268.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,084.65 | 2023-2024 | Ensite, Cardiomems, Xience Skypoint |
| Shockwave Medical, INC | $957.33 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Boston Scientific Corporation | $941.27 | 2021-2025 | Opticross, Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Cardiovascular Systems INC. | $448.47 | 2022-2023 | Diamondback Coronary |
| Amgen INC. | $430.04 | 2021-2025 | Repatha, Repatha |
| Medtronic, INC. | $364.43 | 2022-2024 | Hawkone, Linq II, Micra |
| Inari Medical, INC. | $286.81 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $161.18 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $122.13 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $119.96 | 2022 | |
| Livanova USA, INC. | $108.71 | 2023 | Lifesparc |
| Inspire Medical Systems, INC. | $66.53 | 2025 | Inspire |
| Chiesi USA, INC. | $63.50 | 2023 | Kengreal |
| Novo Nordisk INC | $42.23 | 2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $40.52 | 2024 | Xarelto |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $38.48 | 2024 | Sapien 3 Ultra Resilia |
| Alnylam Pharmaceuticals INC. | $36.58 | 2025 | Onpattro |
| Abiomed | $31.60 | 2021 | |
| Abbvie INC. | $23.87 | 2021 | |
| Mannkind Corporation | $21.00 | 2025 | |
| Esperion Therapeutics, INC. | $18.03 | 2024 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $16.36 | 2025 | Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $15.42 | 2024 | Arcalyst |
| Shire North American Group INC | $15.07 | 2019 | |
| Cleerly, INC. | $13.89 | 2025 | Cleerly Ischemia, Cleerly Labs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.